Presently, as Head of the “Data, Information, Knowledge & Intelligence Group” in PLG, Marco Anelli is coordinating all delivery and research projects (internal and on behalf of clients) linked to Big Data, Knowledge Management, Artificial Intelligence and Machine Learning. He is also Deputy Chief Scientific Officer” of the Company.
Always in PLG, Marco has been “Head of Pharmacovigilance and Medical Affairs Advisory Services” and QPPV. Previously, Marco has been R&D Director at Keypharma, an Italy-based ProductLife Group company, and was responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients.
Drawing on a career in the pharmaceutical industry that spans 25 years, Marco provides expert oversight on a wide range of R&D and Medical Affairs related activities. Marco has participated in and coordinated all stages of drug development – from formulation to Phase I-IV and pharmacovigilance. In addition, Marco is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries. Before joining Keypharma and PLG, Marco was Medical Affairs Director at Eurand. In recent years, he has worked extensively in the fields of Pharmacoeconomics and Health Technology Assessment. In addition to a formal background in computer programming, he has a medical degree from Milan University, specializations in Medical Statistics and Clinical Pharmacology from Pavia University and an international master’s degree in health economics and pharmacoeconomics from Pompeu Fabra University in Barcelona.